Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors
Philipp Sievers(German Cancer Research Center), Pascale Varlet(Inserm), Konstantin Okonechnikov(German Cancer Research Center), Damian Stichel(German Cancer Research Center), Lenka Krsková(Charles University), Guido Reifenberger(Düsseldorf University Hospital), Christina Blume(German Cancer Research Center), Patrick N. Harter(Ludwig-Maximilians-Universität München), Dominik Sturm(German Cancer Research Center), Till Acker(Friedrich-Alexander-Universität Erlangen-Nürnberg), Leonille Schweizer(Goethe University Frankfurt), Henning B. Boldt(University of Southern Denmark), Tuyu Zheng(St. Jude Children's Research Hospital), Daniel Schrimpf(German Cancer Research Center), Christian Mawrin(University Hospital Magdeburg), David R. Ghasemi(German Cancer Research Center), Julia Benzel(German Cancer Research Center), Terri S. Armstrong(The University of Texas MD Anderson Cancer Center), Christine Stadelmann(Universitätsmedizin Göttingen), Mariëtte E.G. Kranendonk(Princess Máxima Center), David Capper(German Cancer Research Center), Wolf Mueller(University Hospital Leipzig), Ofelia Cruz(Hospital Sant Joan de Déu Barcelona), Michal Zápotocký(Charles University), Zied Abdullaev(National Institutes of Health), Aleš Vícha(Charles University), Cinzia Lavarino, Mariona Suñol(Hospital Sant Joan de Déu Barcelona), David Reuß(German Cancer Research Center), Rudi Beschorner(Brain (Germany)), Kenneth Aldape(National Institutes of Health), Mark R. Gilbert(Johns Hopkins University SAIS Bologna Center), Richard G. Grundy(Brain Tumour Research), Patricia Kohlhof‐Meinecke(Klinikum Stuttgart), Nada Jabado(McGill University), Ulrich Schüller(Universität Hamburg), David W. Ellison(St. Jude Children's Research Hospital), Sophie C. Henneken(German Cancer Research Center), Viktoria Ruf(Ludwig-Maximilians-Universität München), Marcel Kool(German Cancer Research Center), Matija Snuderl, Koichi Ichimura(Hiroshima City Asa Citizens Hospital), Kendra K. Maaß(German Cancer Research Center), Martin Sill(German Cancer Research Center), Celso Pouget(Centre Hospitalier Régional et Universitaire de Nancy), Mélanie Pagès(Institut Curie), Hildegard Dohmen(Justus-Liebig-Universität Gießen), Stephanie Bunkowski(Universitätsmedizin Göttingen), Noreen Akhtar(Manchester Royal Infirmary), Sebastian Brandner(University College London)
Cited by 81
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k